Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function
NCT ID: NCT00759044
Last Updated: 2015-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2008-03-31
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Blood-retinal Barrier Functional Alterations by Optical Coherence Tomography
NCT01220804
Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography
NCT00797524
10-year Progression of Diabetic Retinopathy: Identification of Signs and Surrogate Outcomes
NCT04650165
Prediction of Progression of Retinal Ischemia in Diabetes
NCT05581225
Progression of Diabetic Retinopathy. Identification of Signs and Surrogate Outcomes
NCT03010397
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AMD
Patients diagnosed with AMD
No interventions assigned to this group
DME
Patients diagnosed with DME
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with DME
* Age over 18 years
* Inform consent
Exclusion Criteria
* Glaucoma
* Dilatation of the pupil \< 5 mm
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Association for Innovation and Biomedical Research on Light and Image
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
José G Cunha-Vaz, Prof.
Role: PRINCIPAL_INVESTIGATOR
Association for Innovation and Biomedical Research on Light and Image
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AIBILI Clinical Trial Center
Coimbra, Coimbra District, Portugal
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bernardes R, Dias J, Cunha-Vaz J. Mapping the human blood-retinal barrier function. IEEE Trans Biomed Eng. 2005 Jan;52(1):106-16. doi: 10.1109/TBME.2004.839801.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CNTM023A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.